Evidence map›Paper›PMID 35200346›Full record

ReviewBiosensors2022

Recent Advances in Single Fe-Based Nanoagents for Photothermal-Chemodynamic Cancer Therapy.

Li Zhang, Helen Forgham, Ao Shen, Ruirui Qiao, Bing Guo

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Biosensors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. [Manganese-based nanoparticles for chemodynamic therapy of gastrointestinal cancer].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2023
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. PPy@FeFrontiers in bioengineering and biotechnology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Li ZhangShenzhen Key Laboratory of Flexible Printed Electronics Technology and School of Science, Harbin Institute of Technology, Shenzhen 518055, China.
Helen ForghamAustralian Institute of Bioengineering & Nanotechnology, The University of Queensland, Brisbane, QLD 4072, Australia.ORCID 0000-0002-6871-3213
Ao ShenAustralian Institute of Bioengineering & Nanotechnology, The University of Queensland, Brisbane, QLD 4072, Australia.
Ruirui QiaoAustralian Institute of Bioengineering & Nanotechnology, The University of Queensland, Brisbane, QLD 4072, Australia.
Bing GuoShenzhen Key Laboratory of Flexible Printed Electronics Technology and School of Science, Harbin Institute of Technology, Shenzhen 518055, China.ORCID 0000-0001-7981-0644

Funding

Advance Queensland Women's Research Assistance Program AQWRAPNational Health and Medical Research Council APP1196850Science and Technology Innovation Commission of Shenzhen RCBS20200714114910141 and JCYJ20210324132816039Start-up Grant at Harbin Institute of Technology (Shenzhen) HA45001108 and HA11409049UQ Amplify Women's Academic Research Equity UQAWARE
6 · The paper itself

Abstract

Monomodal cancer therapies are often unsatisfactory, leading to suboptimal treatment effects that result in either an inability to stop growth and metastasis or prevent relapse. Thus, synergistic strategies that combine different therapeutic modalities to improve performance have become the new research trend. In this regard, the integration of photothermal therapy (PTT) with chemodynamic therapy (CDT), especially PTT/CDT in the second near-infrared (NIR-II) biowindow, has been demonstrated to be a highly efficient and relatively safe concept. With the rapid development of nanotechnology, nanoparticles can be designed from specific elements, such as Fe, that are equipped with both PTT and CDT therapeutic functions. In this review, we provide an update on the recent advances in Fe-based nanoplatforms for combined PTT/CDT. The perspectives on further improvement of the curative efficiency are described, highlighting the important scientific obstacles that require resolution in order to reach greater heights of clinical success. We hope this review will inspire the interest of researchers in developing novel Fe-based nanomedicines for multifunctional theranostics.

Indexed as

NanoparticlesNeoplasmsCell Line, TumorHumansNanomedicinePhotothermal Therapychemodynamic therapyFe-based nanoplatformsphotothermal therapysecond near-infrared biowindowsynergetic performance

Identifiers

PMID35200346
PMCPMC8869282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.